Aeterna Zentaris
AEZS
$2.62
Share price
-2.24%
Change (1 day)
-71.68%
Change (1 year)
Categories
Earnings for Aeterna Zentaris (AEZS)
Earnings in 2022 (TTM): -$14.42 M
According to Aeterna Zentaris's latest financial reports the company's current earnings (TTM) are -$14.42 M. In 2021 the company made an earning of -$8.21 M a decrease over its 2020 earnings that were of -$6.64 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Aeterna Zentaris from 2002 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$14.42 M | 75.63% |
| 2021 | -$8.21 M | 23.61% |
| 2020 | -$6.64 M | 6.8% |
| 2019 | -$6.22 M | -163.17% |
| 2018 | $9.84 M | -142.65% |
| 2017 | -$23.08 M | -21.72% |
| 2016 | -$29.48 M | -15% |
| 2015 | -$34.68 M | 1.3% |
| 2014 | -$34.24 M | 24.6% |
| 2013 | -$27.48 M | 251.9% |
| 2012 | -$7.81 M | -69.92% |
| 2011 | -$25.96 M | |
| 2008 | -$62.38 M | 79.61% |
| 2007 | -$34.73 M | 43.21% |
| 2006 | -$24.26 M | 364.64% |
| 2005 | -$5.22 M | -137.71% |
| 2004 | $13.84 M | -226.49% |
| 2003 | -$10.95 M | -16.99% |
| 2002 | -$13.19 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $8.37 B | -58,167.43% | 🇨🇭 Switzerland |
 Sanofi SNY | $11.49 B | -79,826.69% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $7.71 B | -53,603.05% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | -$97.91 M | 579.15% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $0.24 B | -1,826.68% | 🇺🇸 USA |